Talk not ready, need approval first!
Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
BJU International
Published October 9, 2026
Long-term outcomes of augmentation cystoplasty for neurogenic lower urinary tract dysfunction aft...
October 9, 2026
Medspoke
Medspoke
Clinical Cancer Research
Published October 8, 2026
00:00
--:--
FIND: a phase-II study to evaluate the efficacy and safety of erdafitinib in FGFR-altered NSCLC.
October 9, 2026
Share
FIND: a phase-II study to evaluate the efficacy and safety of erdafitinib in FGFR-altered NSCLC.
https://www.medspoke.co/channel_journal?id=686&tap_id=15298
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Journal of Clinical Oncology (JCO)
Published October 8, 2026
Prognostic Impact of Telomere Maintenance Mechanisms in Neuroblastoma.
October 9, 2026
Why are you reporting this TALK?
